Polyphenols restore endothelial function in DOCA-salt hypertension:: Role of endothelin-1 and NADPH oxidase

被引:79
|
作者
Jimenez, Rosario
Lopez-Sepulveda, Rocio
Kadmiri, Maria
Romero, Miguel
Vera, Rocio
Sanchez, Manuel
Vargas, Felix
O'Valle, Francisco
Zarzuelo, Antonio
Duenas, Montserrat
Santos-Buelga, Celestino
Duarte, Juan
机构
[1] Sch Med, Dept Physiol, E-18071 Granada, Spain
[2] Sch Med, Dept Pathol Anat, E-18071 Granada, Spain
[3] Univ Salamanca, Sch Pharm, Lab Nutr & Bromatol, E-37007 Salamanca, Spain
关键词
red wine polyphenols; DOCA-salt hypertension; endothelial dysfunction; NADPH oxidase; endothelin-1; free radicals;
D O I
10.1016/j.freeradbiomed.2007.05.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Red wine polyphenols (RWPs) have been reported to exert beneficial effects in preventing cardiovascular diseases, such as hypertension. We studied the effects of chronic treatment with RWPs and apocynin, an inhibitor of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, on blood pressure, endothelial function, and oxidative status in deoxycorticosterone acetate (DOCA)-salt-induced hypertension. Rats were administered RWPs (40 mg/kg) or apocynin (33 mg/kg) daily by gavage for 5 weeks. Plasma catechin levels were detected only after RWP treatment. RWPs and apocynin prevented both the increase in systolic blood pressure and the proteinuria induced by DOCA-salt. Plasma malonyldialdehyde levels, urinary iso-prostaglandin F-2 alpha excretion, aortic superoxide production, and aortic NADPH oxidase activity were found to be increased in animals of the DOCA group. RWP and apocynin treatments reduced these parameters in DOCA-salt rats, having no effect on control rats. However, only RWPs reduced the increase in plasma endothelin-1 (ET-1) levels and aortic p22(phox) gene overexpression found in DOCA-salt animals. RWPs and apocynin also improved the blunted endothelium-dependent relaxation response to acetylcholine in noradrenaline-precontracted aortic rings. All these results suggest that chronic treatment with RWPs prevents hypertension and vascular dysfunction. RWPs prevent vascular oxidative stress by inhibiting NADPH oxidase activity and/or by reducing ET-1 release. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:462 / 473
页数:12
相关论文
共 50 条
  • [31] Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension
    Yu, M
    Gopalakrishnan, V
    Wilson, TW
    McNeill, JR
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (06): : H2511 - H2517
  • [32] Evidence for increased nitric oxide, but not endothelin-1, production in the kidneys of DOCA-salt hypertensive rats
    Allcock, GH
    Venema, RC
    Pollock, JS
    Pollock, DM
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 : P118 - P118
  • [33] PLASMA-CONCENTRATIONS OF ENDOTHELIN-1 IN SPONTANEOUSLY HYPERTENSIVE RATS AND DOCA-SALT HYPERTENSIVE RATS
    SUZUKI, N
    MIYAUCHI, T
    TOMOBE, Y
    MATSUMOTO, H
    GOTO, K
    MASAKI, T
    FUJINO, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 167 (03) : 941 - 947
  • [34] Effect of V1-vasopressin receptor antagonism on small artery structure in the doca-salt rat: Role of endothelin-1
    Intengan, HD
    He, G
    Schiffrin, EL
    JOURNAL OF HYPERTENSION, 1998, 16 : S132 - S132
  • [35] Role of RhoGEF proteins in DOCA-salt induced hypertension
    Lukasova, M.
    Wirth, A.
    Wettschureck, N.
    Gutkind, S.
    Offermanns, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 64 - 65
  • [36] Cicletanine Improves Endothelial Function in DOCA-Salt Hypertensive Rats
    Liang, Faquan
    Shryock, John
    HYPERTENSION, 2010, 56 (05) : E149 - E149
  • [37] Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats
    Nunes, VW
    Fortes, ZB
    Nigro, D
    Carvalho, MHC
    Zorn, TMT
    Scivoletto, R
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 34 (02): : 117 - 125
  • [38] ON THE ROLE OF THE SEPTAL AREA IN THE DEVELOPMENT OF DOCA-SALT HYPERTENSION IN THE RAT
    RICHARDSON, JS
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1983, 5 (03) : 469 - 478
  • [39] ROLE OF TOTAL PERIPHERAL RESISTANCE IN THE DEVELOPMENT OF DOCA-SALT HYPERTENSION
    HUANG, M
    HESTER, RL
    FASEB JOURNAL, 1992, 6 (04): : A1174 - A1174
  • [40] Endothelial dysfunction in DOCA-salt hypertension - Possible involvement of prostaglandin endoperoxides
    Cordellini, S
    GENERAL PHARMACOLOGY, 1999, 32 (03): : 315 - 320